Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, October 14, 2020
RedHill announced collaborations with two specialist pharmaceutical manufacturers in Europe and Canada to ramp-up manufacturing of opaganib.
read more
Wednesday, October 14, 2020
Cambrex announced the completion of an expansion of its solid form screening and crystallization process development facility in Edinburgh, Scotland.
read more
Wednesday, October 14, 2020
Johnson & Johnson announced the EC has approved an Advance Purchase Agreement in which the Janssen will supply 200 million doses of its COVID-19 vaccine candidate to EU Member States following approval or authorization from regulators.
read more
Wednesday, October 14, 2020
LabVantage announced the USAMRAA has awarded the company a contract to supply its LabVantage Pharma LIMS to the Walter Reed Army Institute of Research.
read more
Tuesday, October 13, 2020
PerkinElmer announced the first Turnkey Lighthouse lab in Newport, South Wales, is now processing COVID-19 testing samples as part of the Company’s collaboration with the DHSC in support of the UK Government’s Test and Trace strategy.
read more
Tuesday, October 13, 2020
IonSense has announced the first shipments of their next-generation JumpShot Technology enabled DART source.
read more
Tuesday, October 13, 2020
Indica Labs announced the formal launch of an enterprise-wide, cloud-based deployment of Indica Labs’ software within the National Cancer Institute (NCI), including HALO®, HALO AI, HALO Link and HALO AP.
read more
Tuesday, October 13, 2020
Mogrify announced the introduction of EpiMOGRIFY. The platform models the epigenetic state of the cell to predict the switches important for cell identity, cell maintenance, directed differentiation and cell conversion.
read more
Intec Pharma has entered into a new research collaboration agreement with MSD, the tradename of Merck & Co. Details of the agreement are confidential.
read more
Argonaut announced the California Department of Public Health, FDB has inspected and approved Argonaut’s new Drug Product Manufacturing facility.
read more
CellGenix GmbH has announced the completion of the second phase of their facility expansion.
read more
Centaur will manufacture Vaxart's oral vaccine for COVID-19 and other vaccine candidates.
read more
Abzena has invested $60m into a new facility for late phase and commercial cGMP manufacturing.
read more
Kineta Chronic Pain announced the company will extend and expand its research collaboration with Genentech.
read more
Oxford Biomedica announced the UK MHRA has issued a Certificate of GMP compliance for the fourth GMP manufacturing suite within the Group’s new Oxbox manufacturing facility.
read more